financial
financial

Nestlé to Acquire Dermatology Assets for $1.4 Billion

The Swiss giant is buying the rights to commercialize some products from Valeant Pharmaceuticals International in the U.S. and Canada.

News from WWD
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

LatestPublications
getIsArchiveOnly= hasAccess=false hasArchiveAccess=false